Orwig, Denise L. http://orcid.org/0000-0003-4095-5795
Kopperdahl, David http://orcid.org/0000-0001-6127-5145
Keaveny, Tony http://orcid.org/0000-0003-0258-7178
Magaziner, Jay http://orcid.org/0000-0002-9221-5425
Hochberg, Marc http://orcid.org/0000-0001-7705-5593
Article History
Received: 26 May 2020
Accepted: 5 February 2021
First Online: 22 February 2021
Declarations
:
: Protocols for both the parent study and CT ancillary study were approved by the Institutional Review Boards (IRB) at the University of Maryland Baltimore, as well as by each study hospital’s respective IRBs.
: Informed consent was provided by the hip fracture patient or their proxy.
: Consent for publication of study results was contained within the Informed Consent Document.
: Denise Orwig and Marc Hochberg declare they have no conflicts of interest. David Kopperdahl is an employee of O.N. Diagnostics. Tony Keaveny is Founder and consulting Chief Scientific Officer, O.N. Diagnostics; consulting for Amgen, Agnovos Healthcare, Bone Health Technologies; equity in O.N. Diagnostics. Jay Magaziner has served on advisory boards or consulted for UCB and Pluristem.